Hospital

Health policies to adapt to climate change must be altered to protect individuals with respiratory diseases in the warmer season.

Twenty states proposed bills to prohibit white bagging and brown bagging policies this year.

Researchers determined that simultaneously targeting the BRD4 and LOXL2 proteins disrupts their interaction and inhibits the growth of triple-negative breast cancer cells.

Women with inflammation during COVID-19 infection are at higher risk for Long Covid symptoms, according to study results.

With this approval, fruquintinib is the first and only selective inhibitor of all 3 VEGR receptor kinases to be approved in the United States for previously treated mCRC, regardless of biomarker status.

Socioeconomic, racial, and insurance disparities impact individuals' health before and after receiving surgery to treat adolescent idiopathic scoliosis.

Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.

Domvanalimab plus zimberelimab with chemotherapy demonstrated a positive overall response rate and 6-month progression free survival rate for patients with upper gastrointestinal cancers.

More individuals with systemic lupus erythematosus treated with anifrolumab-fnia reached remission compared to the placebo.

Data show patients are willing to accept associated risks for a chance at a cure.

CD4+ tissue-resident memory T cells may trigger severe, and potentially fatal, asthma attacks in men aged 40 years and older.

Changes in gene expression could ultimately boost the production of inflammatory cytokines.

With the organism’s potential to cause severe symptoms, severe disease, and possible death, it is essential to care for infected individuals promptly and safely.

It's key for clinicians to optimize therapy prior to systemic agents.

More individuals who used e-cigarettes have reported pulmonary diseases compared with those who never smoked, including asthma.

Regular usage of cannabis may increase the risk of heart failure, stroke, or heart attack, even after adjusting for other cardiovascular disease risk factors.

AI may help to significantly speed up drug discovery and development, and help researchers end the treatment-resistant infection crisis before it’s too late.

With precision medicine, patients undergoing treatment are living longer without disease recurrence or progression and with fewer adverse effects, resulting in preservation of quality of life.

Infants younger than 6 months old are the highest risk for severe RSV infection, so researchers aim to target this group for prevention methods

AI is expected to significantly quicken the pace of drug design and development, while improving the success rate of new medicines.

This comprehensive approach is what all stakeholders, especially patients and families, need and deserve from their health care system.

The need for additional data on safety and efficacy of medicines both new and old that assess all potential risk factors is ever present, with health system pharmacists at the front lines.

Risk of atrial fibrillation with 1 of the independent predictors, including congestive heart failure and left atrial enlargement, resulted in greater than a 4-fold increased detection.

Children with a score of higher than 30 on the CHALF Score scale will need an emergency transplant.

Although SGLT2 inhibitors are not a cure of diabetic kidney disease, this treatment can help reduce the risk and manage the disease either alone or with complementary therapies.

Deep-rooted discrimination and stigma can contribute to stressors that worsen disease progression and access to care, according to experts.

Other than dialysis, Shah notes that patients with kidney disease who are pregnant can receive either nifedipine or labetalol to control blood pressure.

Nickolas also describes how the use of novel imaging technologies, microRNA, and transcriptomics help experts better understand underlying pathogenesis of ROD.

Understanding the mechanisms leading to weight loss could help identify potential benefits for cardiorenal health in patients with chronic kidney disease.

Sodium-glucose cotransporter-2 inhibitors and sodium zirconium cyclosilicate may be paired with these kidney disease medications to reduce high serum potassium.